Kenneth Edwin Schmader, MD

Professor of Medicine
Director of the GRECC and ACOS for Geriatrics and Extended Care
Senior Fellow in the Center for the Study of Aging and Human Development
Campus mail Duke Box 3469, Durham, NC 27710
Phone (919) 660-7572
Email address schma001@mc.duke.edu

Dr. Schmader’s areas of research include herpes zoster, infections, and vaccines in older adults.  He conducts translational, clinical trials and observational studies of herpes zoster, influenza, pneumococcal and respiratory syncytial vaccines and other infections funded by grants from the National Institute on Aging (NIA), National Institute of Allergy and Infectious Diseases (NIAID), Centers for Disease Control (CDC), VA Office of Research and Development, and Industry sources.  He has played a pivotal role in the development of zoster vaccines in older adults.  Dr. Schmader also performs research in medications and older adults, focusing on pharmacoepidemiology, optimal drug use and reduction of adverse drug reactions.

He is the Director of the NIA-funded P30 Duke Pepper Older Americans Independence Center and Co-PI of the NIAID funded Vaccine and Therapeutics Effectiveness Unit (VTEU) at Duke.  He serves on the Working Groups for the Herpes Zoster, Influenza, and General Adult Immunization Guidelines for the US Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) and is the American Geriatrics Society liaison to the ACIP.

Education and Training

  • Fellow in Geriatrics, Medicine, Duke University, 1986 - 1988
  • Chief Medical Resident, Medicine, University of Wisconsin at Madison, 1983 - 1983
  • Medical Resident, Medicine, University of Wisconsin at Madison, 1980 - 1983
  • M.D., Wake Forest University, 1980

Grants

Publications

Hanlon, Joseph T., Lawrence R. Landerman, Margaret B. Artz, Shelly L. Gray, Gerda G. Fillenbaum, and Kenneth E. Schmader. “Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly..” Pharmacoepidemiol Drug Saf 13, no. 11 (November 2004): 781–87. https://doi.org/10.1002/pds.952.

PMID
15386717
Full Text

Hanlon, J. T., and K. E. Schmader. “Three articles concerning pain management in the elderly.” American Journal Geriatric Pharmacotherapy 2, no. 3 (September 1, 2004): 155–56. https://doi.org/10.1016/S1543-5946(04)80002-3.

Full Text

Coplan, Paul M., Kenneth Schmader, Alexander Nikas, Ivan S. F. Chan, Peter Choo, Myron J. Levin, Gary Johnson, et al. “Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory..” J Pain 5, no. 6 (August 2004): 344–56.

PMID
15336639
Scholars@Duke

McGarry, Sarah A., John J. Engemann, Kenneth Schmader, Daniel J. Sexton, and Keith S. Kaye. “Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost..” Infect Control Hosp Epidemiol 25, no. 6 (June 2004): 461–67. https://doi.org/10.1086/502422.

PMID
15242192
Full Text

Fillenbaum, Gerda G., Joseph T. Hanlon, Lawrence R. Landerman, Margaret B. Artz, Heidi O’Connor, Bryan Dowd, Cynthia R. Gross, Chad Boult, Judith Garrard, and Kenneth E. Schmader. “Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents..” Am J Geriatr Pharmacother 2, no. 2 (June 2004): 92–101.

PMID
15555485
Scholars@Duke

Schmader, Kenneth E., Joseph T. Hanlon, Carl F. Pieper, Richard Sloane, Christine M. Ruby, Jack Twersky, Susan Dove Francis, et al. “Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly..” Am J Med 116, no. 6 (March 15, 2004): 394–401. https://doi.org/10.1016/j.amjmed.2003.10.031.

PMID
15006588
Full Text

Schmader, K. “Herpes Zoster in the Long-Term Care Setting.” Annals of Long Term Care 12, no. 1 (January 1, 2004): 38–42.

Scholars@Duke

Hanlon, J. T., and K. E. Schmader. “A case series, reviews, and an approach to improving adherence in older patients with chronic heart failure.” American Journal Geriatric Pharmacotherapy 2, no. 1 (January 1, 2004): 1–2. https://doi.org/10.1016/S1543-5946(04)90001-3.

Full Text

Pages